In Japan, CBD can be expensive: the forced resignation of a Suntory boss
When Takeshi Niinami, the influential former president of the Japanese beverage giant Suntory, announced her resignation, it was not due to financial misconduct, mismanagement of the company, or a political scandal. Rather, it was due to something that, in most countries of the world, would have hardly caused any reaction: her use of CBD dietary supplements to combat jet lag.
As reported by the New York Times, M. Niinami admitted to purchasing dietary supplements containing cannabidiol (CBD) in the United States. At a press conference in Tokyo, he confessed: «I believe I have not broken any laws and am innocent.» He clarified that he had never consumed or possessed these products on Japanese soil.
Despite his insistence, Japanese authorities have opened an investigation under the Narcotics Control Act, one of the world's strictest anti-drug frameworks. The investigation alone was enough to cost Niinami his job at Suntory, where the board said he showed a «lack of conscience» incompatible with his executive role.
CBD and the weight of stigma
According to the’Associated Press, Niinami explained that the CBD dietary supplement It had been recommended to him by a friend in the United States, who had assured him that it was «100% legal.» He intended to use it to alleviate jet lag during his frequent business trips abroad. But a package sent to his home in Tokyo never reached him, and another package intended for him was reportedly intercepted, triggering the police investigation.
In many countries, this story would have ended there, as an anecdote about a high-ranking official resorting to natural remedies to combat travel fatigue. In Japan, however, in a zero-tolerance environment, It degenerated into a national controversy.
Niinami's resignation, a Harvard-educated executive who played a pivotal role in transforming Suntory into a global powerhouse, illustrates the disproportionate consequences from Japan's uncompromising stance. He was not accused of drunkenness, professional misconduct, or abuse of power. His only «fault» was considering taking a dietary supplement legally sold in Europe and the United States. An absurd situation against a backdrop of outdated legislation.
As Niinami himself stated, «It was my negligence that led to this situation when I purchased these dietary supplements. I apologize for the uproar this has caused.»
His apology, presented in accordance with Japanese culture of public contrition, highlights how corporate reputation and accountability can outweigh actual evidence of wrongdoing.
The Japanese drug laws are among the strictest in the world, criminalizing not only the consumption, but also the possession of cannabis in all its forms. High-profile individuals, from athletes to artists, have faced public shame and legal repercussions for minor offenses that would barely be noticed elsewhere.
And‘The irony is striking: a leader of a global alcohol brand is forced to resign, not for a controversy related to alcohol abuse or his company's impact on public health, but for a legal and harmless product in the very markets where he developed his business.
-
Cannabis in Europe4 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France3 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.4 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Business3 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon
-
Cannabis in Thailand4 weeks ago
Thailand Threatens Cannabis Shops with Severe Penalties
-
Business4 weeks ago
The British medical cannabis market is expected to exceed 140,000 patients by 2026
-
Cannabis in Australia2 weeks ago
South Australia is working to identify more water-efficient hemp varieties
-
Exchange4 weeks ago
Glass House will be the second U.S. cannabis company to list on the New York Stock Exchange


cbdtech
September 6, 2025 at 9:00 AM
As Mr. Niinami's case in Japan shows, many Asian countries, including Japan, have very strict laws and do not distinguish between CBD and THC. For them, both are often considered controlled or illegal substances, and penalties can be severe. Fabien CBDtech